Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

CSF constitutents as mediators of brain damage in demyelinating diseases of the central nervous system

Project Overview

Most nerves in the brain are surrounded by myelin, an insulating cover that allows them communicate efficiently. Brain damage in multiple sclerosis (MS) results from two, partially independent processes. On one side there are recurring attacks of immune cells on the myelin, which are responsible for development of new symptoms that then typically improve to variable extent. On the other side, there is a gradual loss of neurons which causes progressive worsening of physical and mental symptoms. This second process is the major cause of disability in people with MS and not much is known about what causes it. The current treatments for MS modulate the immune system to prevent attacks, but do not have much effect on the gradual worsening of symptoms. Recent research has shown that lesions near the brain surface are common in people with progressive MS, and the loss of neurons is also worst near the surface. This pattern of damage suggests a process driven by some harmful factors diffusing into the brain from the fluid that surrounds it, called cerebrospinal fluid (CSF). It was thought that this pattern of injury at the brain surfaces only happened in MS, but more recently a similar pattern has been found in a newly recognized disease called myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD). The goal of this research is to analyze the CSF in people with MS and MOGAD and look for substances in the CSF that are most concentrated in people who also have the strongest brain-surface damage, as measured through MRI. The overall objective of this project is to discover what causes the damage at the brain surface in both MS and MOGAD, develop tools to predict how well patients will do in the future, and provide new targets for developing therapies to stop disease progression.

Principal Investigator

Giulia Fadda , Université d’Ottawa / University of Ottawa

Partners and Donors

Azrieli Foundation

Project Ongoing

CSF constitutents as mediators of brain damage in demyelinating diseases of the central nervous system

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Multiple Sclerosis

  • Competition

    Future Leaders in Canadian Brain Research

  • Province

    Ontario

  • Start Date

    2023

  • Total Grant Amount

    $100,000

  • Health Canada Contribution

    $50,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2025 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co

  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds
Project Directory
Donate Now